A. Taylor Bright, PhD, is co-founder and COO of Novoron Bioscience, Inc., which is developing novel therapeutics for diseases of the central nervous system. Dr. Bright is also a partner at ScholarNexus, LLC, which helps companies spin-out of academic settings through the use of non-dilutive federal grant funding. He has over 10 years of experience in academic and industrial biomedical research, operations, and finance. Dr. Bright was selected to participate in the inaugural ICorps@NIH where he learned how to adapt the business model canvas and lean startup methods to the biological sciences. Dr. Bright received his PhD in Biomedical Sciences from the University of California, San Diego. He also holds an AB in Molecular Biology from Princeton University.
Novoron Bioscience, Inc.
Co-founder and COO